Table 3
Accuracy of MDCT according to the presence and absence of SPECT-SRS ⩾2 without/with corresponding significant stenoses on CCA in the infarct-related territory
| SPECT-SRS ⩾2 | SPECT-SRS ⩾2 plus CCA | |
| CTA (culprit lesion 50%) | ||
| Sensitivity | 93.8% (60/64) | 98.4% (60/61) |
| Specificity | 18.6% (8/43) | 23.9% (11/46) |
| Negative predictive value | 66.7% (8/12) | 91.7% (11/12) |
| Positive predictive value | 63.2% (60/95) | 63.2% (60/95) |
| Accuracy | 63.6% (68/107) | 68.2% (71/107) |
| MDCT-jeopardised score (2.5) plus CTA (culprit lesion 50%) | ||
| Sensitivity | 85.9% (55/64) | 90.2% (55/61) |
| Specificity | 79.1% (34/43) | 80.4% (37/46) |
| Negative predictive value | 79.1% (34/43) | 86.0% (37/43) |
| Positive predictive value | 85.9% (55/64) | 85.9% (55/64) |
| Accuracy | 83.2% (89/107) | 86.0% (92/107) |
